A round-up of the #QWINT phase 3 clinical trials evaluating once-weekly #insulin efsitora alfa in people with diabetes, including data simultaneously published and presented at the ADA's 85th Scientific Sessions.

👉 buff.ly/5IZShab

#Diabetes

Three panelists, Harpreet Bajaj, Carol Wysham, and Rich Bergenstal, seated and holding microphones during a discussion about once-weekly insulin therapy. The image features the EASD logo in the top right corner, with a soundwave graphic and the text 'Once weekly insulins' below the panelists

Ep. 8 of #DiabetesInsights explores the #QWINT programme, a once-weekly #insulin therapy redefining basal insulin replacement!

Learn how this innovation:

✅Reduces injection burden (17-day half-life)
✅Shows promise for #t2d
✅Faces challenges in #t1d

🎙Tune in now: www.easd.org/media-centre...